Nimodipine Impurity F
|
尼莫地平雜質(zhì)F
|
39562-18-0
|
Nimodipine Impurity B
|
尼莫地平雜質(zhì)B
|
21881-78-7
|
1-(2,4-dinitrophenyl)pyridinium chloride
|
氯化-1-(2.4-二硝基苯基)吡啶翁鹽
|
4185-69-7
|
(2E,4E)-5-(aniline)penta-2,4-dienal
|
(2E,4E)-5-(苯胺基)戊-2,4-二烯醛
|
17432-66-5
|
2-(4-phenoxybenzoyl)malononitrile
|
330792-68-2
|
N-Nitroso Metoprolol
|
N-亞硝基美托洛爾
|
138768-62-4
|
Naltrexone
|
納曲酮
|
16590-41-3
|
AZD-9574
|
AZD-9574
|
2756333-39-6
|
Compound T24622
|
化合物 T24622
|
1467059-66-0
|
6-fluoro-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine
|
6-氟-3-(1H-吡咯并[2,3-c]吡啶-1-基)異喹啉-5-胺
|
1841078-87-2
|
(R)-GAMMA-VALEROLACTONE
|
(R)-二氫-5-甲基-2(3H)-呋喃酮
|
58917-25-2
|
N-Deshydroxyethyl Dasatinib
|
N-脫羥基乙基達(dá)沙替尼
|
910297-51-7
|
α-Hydroxy Olopatadine
|
α-羥基奧洛他定鹽酸鹽
|
1331668-21-3
|
M1-Impurity A [2-(2,4-dichloro-5-fluorobenzoyl)-3-(ethylamino)acrylate
|
M1-雜質(zhì)A【2-(2,4-二氯-5-氟苯甲?;?3-(乙氨基)丙烯酸酯】
|
104600-28-4
|
3-Pyrrolidinol
|
3-羥基吡咯烷
|
40499-83-0
|
Tretinoin EP Impurity G
|
維A酸EP雜質(zhì)G
|
13100-69-1
|
N-Methylcaprolactam
|
N-甲基己內(nèi)酰胺對(duì)照品
|
2556-73-2
|
Phenylbutyryl chloride
|
苯丁酰氯
|
18496-54-3
|
3-[(3-Fluorobenzyl)oxy]benzaldehyde
|
3-(3-氟芐氧基)苯甲醛
|
590353-54-1
|
(S)-2-((4-((3-fluorobenzyl)oxy)benzylidene)amino)propanamide
|
(S)-2-[(4-((3-氟芐基)氧基)亞芐基)氨基]丙酰胺
|
1000370-31-9
|
(S)-2-(3-fluorobenzylamide)propionamide
|
(S)-2-(3-氟芐胺基)丙酰胺
|
1132879-89-0
|
(S)-2-(4-(3-chlorobenzyloxy)benzylamido)propionic acid
|
(S)-2-(4-(3-氯芐氧基)芐胺基)丙酸
|
1160513-60-9
|
2,3-Dihydroxypropyl 4-phenylbutyrate
|
2,3-二羥丙基 4-苯基丁酸酯
|
1292210-87-7
|
(S)-2-(4-(3-fluorobenzyloxy)benzylamido)propanol
|
(S)-2-(4-(3-氟芐氧基)芐胺基)丙醇
|
1376616-14-6
|
Methyl lipoate
|
硫辛酸甲酯
|
46236-19-5
|
2-(3-ethoxyphenoxy)bromoethane
|
2-(3-乙氧基苯氧基)溴乙烷
|
26690-39-1
|
Cefazolin sodium USP Impurity E
|
頭孢唑林鈉USP雜質(zhì)E
|
478494-71-2
|
Azilsartan Impurity SM01-8
|
阿齊沙坦雜質(zhì)SM01-8
|
177965-03-6
|
Fluocinolone EP Impurity A
|
氟輕松EP雜質(zhì)A
|
106931-78-6
|
Fluocinolone EP Impurity E
|
氟輕松EP雜質(zhì)E
|
68352-03-4
|
LGLT-ZZ-70
|
阿格列汀雜質(zhì)
|
397246-12-7
|
Diisopropyl hydrazine dicarboxylate
|
肼二甲酸二異丙酯
|
19740-72-8
|
R)-tert-Butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate
|
(3R)-3-[4-氨基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶基]-1-叔丁氧羰基碳酸酯
|
1022150-11-3
|
4-(3-(4-guanidinobenzoyl)guanidinyl)benzoic acid
|
2491698-53-2
|
(S)-(5-broMo-2-chlorophenyl)(4- (tetrahydrofuran-3-yloxy)phenyl) Methanone
|
(5-溴-2-氯苯基)[4-[[(3S)-四氫-3-呋喃基]氧基]苯基]甲酮
|
915095-84-0
|
Methotrexate Impurity SM2-4 (2-Phenyl-1,3-Dioxane-5-one)
|
甲氨蝶呤雜質(zhì)SM2-4(2-苯基-1,3-二惡烷-5-酮)
|
52941-82-9
|
1,3-Dimethylamino-2-propanol
|
1,3-二甲氨基-2-丙醇
|
83804-96-0
|
1-Ethyl-3-(4-phenoxyphenyl)-1H-pyrazole[3,4-d]pyrimidin-4-amine
|
1-乙基-3-(4-苯氧基苯基)-1H-吡唑[3,4-d]嘧啶-4-胺
|
2213398-76-4
|
Fluvoxamine Impurity Ⅳ
|
馬來酸氟伏沙明雜質(zhì)Ⅳ
|
89035-92-7
|
Fluvoxamine Impurity I
|
馬來酸氟伏沙明雜質(zhì)I
|
259526-43-7
|
Fluvoxamine Impurity Ⅱ
|
馬來酸氟伏沙明雜質(zhì)Ⅱ
|
1217214-94-2
|
Fluvoxamine maleate impurity III. Dimaleate
|
馬來酸氟伏沙明雜質(zhì)Ⅲ 二馬來酸鹽
|
|
N-(4-Pyridyl)-2-Hydroxybutyramide
|
N-(4-吡啶基)-2-羥基丁酸
|
1864897-67-5
|
Cefuroxime axetil Impurity A
|
頭孢呋辛酯雜質(zhì)A
|
123458-61-7
|
2-Nitroaniline
|
2-硝基苯胺
|
88-74-4
|
Emedastine Impurity INT3-G
|
依美斯汀雜質(zhì)INT3-G
|
40019-65-6
|
Diethyl 2-(6-bromohexyl)malonate
|
2-(6-溴己基) 丙二酸二乙酯
|
6557-85-3
|
Sildenafil dieth
|
西地那非二醚
|
1346602-67-2
|
Cisatracurium Besilate EP Impurity G
|
苯磺順阿曲庫銨EP雜質(zhì)R
|
64228-84-8
|
Coenzyme Q9
|
輔酶Q9對(duì)照品
|
303-97-9
|
Tretinoin EP Impurity C
|
維A酸EP雜質(zhì)C
|
3555-80-4
|
Tretinoin EP Impurity B
|
維A酸EP雜質(zhì)B
|
5352-74-9
|
Tretinoin EP Impurity F
|
維A酸EP雜質(zhì)F
|
81121-20-2
|
Tretinoin EP Impurity D
|
維A酸EP雜質(zhì)D
|
005300-03-8
|
(Z)-Cocoa acid
|
(Z)-可可酸
|
62163-44-4
|
Piperonyl chloride
|
胡椒基氯
|
20850-43-5
|
Compound D2157
|
化合物 D2157
|
|
Impurity I (norhydroxymorphone)
|
雜質(zhì)I(去甲羥基嗎啡酮)
|
|
(E)-Cocoa acid
|
(E)-可可酸
|
62163-45-5
|
Cilnidipine Impurity 3
|
西尼地平雜質(zhì)3
|
99522-79-9
|
2,6-DI-TERT-BUTYL-4-THIOCYANATO-PHENOL
|
2,6-二叔丁基-4-硫氰基苯酚
|
3957-71-9
|